Volume : 13, Issue : 05, May – 2026
Title:
METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF DICLOFENAC SODIUM AND BENZYL ALCOHOL IN GEL FORMULATION
Authors :
Mr. Dhananjay S. Nalinde, Dr. Sachin C. Kale, Dr.B. N. Thakare, Dr.K. R. Biyani
Abstract :
A precise, accurate, and stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) method was created and approved for the simultaneous measurement of benzyl alcohol and diclofenac sodium in gel formulation. Potassium dihydrogen phosphate buffer and acetonitrile (60:40 v/v) were used as the mobile phase in a C18 column to accomplish chromatographic separation at a flow rate of 1.0 mL/min. The wavelength used for detection was 240 nm. For Diclofenac Sodium and Benzyl Alcohol, the developed method yielded symmetrical, well-resolved peaks with retention durations of 3.146 and 6.142 minutes. For linearity, accuracy, precision, specificity, robustness, ruggedness, LOD, and LOQ, the method was validated in accordance with ICH requirements. For both analytes, correlation coefficient values were more than 0.998. Recovery studies showed adequate percentage recovery values and great precision. The technique was effectively used to analyze commercial gel compositions for routine quality control.
Keywords: gel formulation, simultaneous estimation, pharmaceutical analysis, Diclofenac sodium, benzyl alcohol, RP-HPLC, stability-indicating method, and method validation
Cite This Article:
Please cite this article in press Dhananjay S. Nalinde et al., Method Development And Validation Of Rp-Hplc Method For The Estimation Of Diclofenac Sodium And Benzyl Alcohol In Gel Formulation., Indo Am. J. P. Sci, 2026; 13(05).,
REFERENCES:
1. International Council for Harmonisation. (2023). ICH Q2(R2): Validation of analytical procedures—Text and methodology. Geneva, Switzerland: ICH.
2. U.S. Food and Drug Administration. (2022). Analytical procedures and methods validation for drugs and biologics: Guidance for industry. Silver Spring, MD: FDA.
3. United States Pharmacopeial Convention. (2023). United States Pharmacopeia and National Formulary (USP 46–NF 41). Rockville, MD: USP.
4. European Directorate for the Quality of Medicines. (2024). European Pharmacopoeia (11th ed.). Strasbourg, France: EDQM.
5. Snyder, L. R., Dolan, J. W., & Kirkland, J. J. (2022). Introduction to modern liquid chromatography (3rd ed.). Hoboken, NJ: Wiley.
6. Dong, M. W. (2021). Modern HPLC for practicing scientists. Hoboken, NJ: Wiley.
7. Kazakevich, Y., & Lobrutto, R. (2021). HPLC for pharmaceutical scientists. Hoboken, NJ: Wiley.
8. Meyer, V. R. (2022). Practical high-performance liquid chromatography (5th ed.). Chichester, UK: Wiley.
9. Ahuja, S., & Dong, M. W. (2021). Handbook of pharmaceutical analysis by HPLC. San Diego, CA: Academic Press.
10. Poole, C. F. (2022). Chromatography today (2nd ed.). Amsterdam, Netherlands: Elsevier.
11. Skoog, D. A., Holler, F. J., & Crouch, S. R. (2021). Principles of instrumental analysis (7th ed.). Boston, MA: Cengage Learning.
12. Willard, H. H., Merritt, L. L., Dean, J. A., & Settle, F. A. (2021). Instrumental methods of analysis. New Delhi, India: CBS Publishers.
13. Gupta, V. K., Jain, R., & Radhapyari, K. (2022). Chromatographic techniques in pharmaceutical analysis. Critical Reviews in Analytical Chemistry, 52(3), 210–225.
14. Smith, R. M. (2023). Advances in liquid chromatography for pharmaceutical analysis. Journal of Chromatography A, 1685, 463–472.
15. Lunn, G., & Sansone, E. B. (2021). HPLC methods for pharmaceutical analysis. Hoboken, NJ: Wiley.
16. Snyder, L. R., Dolan, J. W. (2022). High-performance liquid chromatography optimization strategies. Journal of Chromatography Science, 60(4), 301–315.
17. McNair, H. M., & Miller, J. M. (2021). Basic gas chromatography (3rd ed.). Hoboken, NJ: Wiley.
18. Fritz, J. S. (2022). Ion exchange chromatography fundamentals. New York, NY: Wiley.
19. Poole, S. K., & Poole, C. F. (2023). Pharmaceutical chromatography: Applications and trends. Journal of Pharmaceutical Analysis, 13(1), 45–58.
20. Kazakevich, Y. (2024). Recent developments in LC-MS techniques. Analytical Chemistry, 96(2), 120–135.
21. Patel, D., Shah, R., & Mehta, P. (2024). Advances in RP-HPLC method development. Journal of Pharmaceutical Analysis, 14(2), 155–163.
22. Hirpara, K., Patel, J., & Desai, H. (2023). Analytical methods for gel formulations. Asian Journal of Pharmaceutical Sciences, 18(1), 45–53.
23. Asghar, S., Khan, M., & Ali, R. (2023). Robust RP-HPLC method for pharmaceutical gels. Journal of Chromatographic Science, 61(5), 410–418.
24. Korodi, G., Nagy, L., & Kovacs, Z. (2022). Stability-indicating RP-HPLC method. Journal of Pharmaceutical and Biomedical Analysis, 215, 114765.
25. Shaalan, R., Ahmed, S., & Hassan, M. (2022). HPLC-DAD method validation. Microchemical Journal, 175, 107–115.
26. Dhaneshwar, S., Deshpande, P. (2021). RP-HPLC quantification of diclofenac. Indian Journal of Pharmaceutical Sciences, 83(2), 245–252.
27. Atto, A., El-Bagary, R., & Elkady, E. (2021). Cost-effective RP-HPLC method development. Journal of AOAC International, 104(3), 678–685.
28. Hanysova, L., & Novakova, L. (2021). Chromatographic analysis of NSAIDs. Journal of Separation Science, 44(6), 1201–1210.
29. Belal, F., & Ibrahim, F. (2021). Stability-indicating RP-HPLC method. Talanta, 223, 121–129.
30. Tsina, I., & Kachrimanis, K. (2021). LC method validation approaches. Pharmaceutics, 13(4), 456.
31. Johnson, M., & Brown, T. (2022). Importance of method validation in pharmaceuticals. Journal of Pharmaceutical Sciences, 111(5), 1400–1410.
32. Kasture, A., & Wadher, S. (2022). Pharmaceutical analysis overview. International Journal of Pharmaceutical Sciences, 14(3), 220–230.
33. Snyder, L. R., & Dolan, J. W. (2022). Chromatographic parameter optimization. LCGC North America, 40(2), 100–110.
34. Lunn, G. (2021). Method development strategies in HPLC. Journal of Pharmaceutical and Biomedical Analysis, 195, 113–120.
35. Jeffery, G. H., Bassett, J., Mendham, J., & Denney, R. C. (2021). Quantitative chemical analysis. New York, NY: Pearson.
36. Sharma, V., & Gupta, R. (2022). UV spectrophotometric methods. Spectrochimica Acta Part A, 267, 120–128.
37. Singh, P., & Verma, A. (2023). UV method development in pharmaceuticals. Journal of Applied Spectroscopy, 90(2), 350–358.
38. Patil, S., & Kulkarni, A. (2022). Spectroscopic techniques in drug analysis. Indian Journal of Chemistry, 61B, 1120–1128.
39. Kaur, H., & Kaur, G. (2021). Applications of UV-visible spectroscopy. Analytical Chemistry Letters, 11(4), 567–575.
40. Reddy, M., & Rao, P. (2024). Simultaneous estimation using UV spectroscopy. Journal of Pharmaceutical Sciences, 113(3), 890–898.
41. Gupta, R., & Singh, S. (2023). Advances in analytical techniques. Journal of Pharmaceutical Research, 17(2), 150–160.
42. Patel, D., et al. (2024). Stability-indicating RP-HPLC method for diclofenac. Journal of Pharmaceutical Analysis, 14(2), 155–163.
43. Hirpara, K., et al. (2023). RP-HPLC and UV methods for gel analysis. Asian Journal of Pharmaceutical Sciences, 18(1), 45–53.
44. Asghar, S., et al. (2023). Diclofenac gel RP-HPLC analysis. Journal of Chromatographic Science, 61(5), 410–418.
45. Korodi, G., et al. (2022). Stability method for diclofenac gel. Journal of Pharmaceutical and Biomedical Analysis, 215, 114765.
46. Shaalan, R., et al. (2022). HPLC-DAD method study. Microchemical Journal, 175, 107–115.
47. Dhaneshwar, S., et al. (2021). Diclofenac quantification method. Indian Journal of Pharmaceutical Sciences, 83(2), 245–252.
48. Atto, A., et al. (2021). RP-HPLC method for pharmaceutical analysis. Journal of AOAC International, 104(3), 678–685.
49. Hanysova, L., et al. (2021). HPLC evaluation of diclofenac. Journal of Separation Science, 44(6), 1201–1210.
50. Belal, F., et al. (2021). Stability RP-HPLC study. Talanta, 223, 121–129.
51. Tsina, I., et al. (2021). LC validation methods. Pharmaceutics, 13(4), 456.
52. Johnson, M., et al. (2022). Validation review. Journal of Pharmaceutical Sciences, 111(5), 1400–1410.
53. Kasture, A., et al. (2022). Chromatography review. International Journal of Pharmaceutical Sciences, 14(3), 220–230.
54. Snyder, L., et al. (2022). LC fundamentals. Journal of Chromatography, 60(4), 301–315.
55. Lunn, G., et al. (2021). HPLC applications. Journal of Pharmaceutical Analysis, 11(2), 200–210.
56. Jeffery, G., et al. (2021). Quantitative analysis methods. Analytical Chemistry, 93(1), 50–60.
57. Sweetman, S. (2023). Martindale: The complete drug reference. Pharmaceutical Press.
58. DrugBank. (2024). Diclofenac sodium profile. Retrieved from https://go.drugbank.com
59. United States Pharmacopeia. (2023). Benzyl alcohol monograph. USP.
60. European Medicines Agency. (2024). Preservative guidelines. EMA.
61. World Health Organization. (2023). Drug safety guidelines. WHO.
62. ICH. (2023). Validation guidelines.
63. FDA. (2022). Method validation guidance.
64. USP. (2023). Analytical procedures.
65. EMA. (2024). Validation recommendations.
66. WHO. (2021). Analytical method validation.
67. Patel, K., & Shah, D. (2022). RP-HPLC optimization study. Pharmaceutical Development and Technology, 27(6), 650–658.
68. Mehta, P., & Jain, S. (2023). Method development approaches. Journal of Pharmaceutical Research, 20(4), 300–308.
69. Sharma, N., & Gupta, S. (2022). Standard preparation techniques. International Journal of Drug Development, 13(1), 45–52.
70. Kumar, A., & Singh, V. (2023). Calibration curve analysis. Analytical Methods, 15(5), 600–608.
71. Singh, R., & Patel, H. (2022). Linearity evaluation methods. Journal of Pharmaceutical Sciences, 111(3), 800–808.
72. Deshmukh, N., & Patil, R. (2024). System suitability studies. International Journal of Pharmaceutical Sciences, 16(2), 120–128.
73. Patil, R., & Kulkarni, A. (2023). Method validation techniques. Pharmaceutical Analysis Journal, 15(2), 90–100.
74. Gupta, S., & Jain, D. (2022). Accuracy and recovery studies. Journal of Pharmaceutical Research, 18(1), 50–58.
75. Jain, D., & Sharma, V. (2023). Recovery method validation. Indian Journal of Pharmaceutical Sciences, 85(2), 200–210.
76. Kulkarni, A., & Patil, S. (2022). Precision analysis in pharmaceuticals. Analytical Chemistry Letters, 12(3), 350–360.
77. Verma, P., & Singh, A. (2023). LOD and LOQ evaluation methods. Journal of Analytical Chemistry, 78(4), 450–460.
78. Shah, R., & Mehta, P. (2024). Robustness and ruggedness studies. Journal of Pharmaceutical Analysis, 14(3), 200–210.




